Contract manufacturing giant Catalent has wrapped up the expansion of a clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
The company is also cutting 400 temporary and full-time workers in Bloomington, Indiana and more than 210 workers in Texas and Maryland.
In a statement from Bloomington, Indiana Mayor John Hamilton blames the layoffs on cooling demand for COVID-19 therapies. “My understanding is that in responding to the pandemic, Catalent significantly ramped up operations to accommodate the manufacturing of life-saving vaccines, but at present, the same volume of production is not necessary and thus is not economically sustainable as before,” Hamilton said.
After an inspection this summer, the FDA recommended that Catalent conduct voluntary quality improvements at the Bloomington site.
In addition, Catalent has halted construction on the Vaccine Manufacturing and Innovation Centre near Oxford in …